for Health Care Providers
Drug rash: nonnucleoside reverse transcriptase inhibitor associated
Pediatric AIDS Pictoral Atlas, Baylor International Pediatric AIDS Initiative
Nonnucleoside reverse transcriptase inhibitor-associated rash on a 12-year-old girl who had begun antiretroviral therapy with efavirenz (Sustiva) 1 week previously. Rash is one of the most common side effects observed with nonnucleoside reverse transcriptase inhibitors.